ProPhase Labs (PRPH) to Release Earnings on Thursday

ProPhase Labs (NASDAQ:PRPH) will be announcing its earnings results before the market opens on Thursday, May 9th. Analysts expect the company to announce earnings of ($0.28) per share for the quarter. Persons that are interested in participating in the company’s earnings conference call can do so using this link.

ProPhase Labs (NASDAQ:PRPH) last issued its quarterly earnings results on Thursday, March 28th. The company reported ($0.51) earnings per share for the quarter. The company had revenue of $3.50 million during the quarter, compared to analyst estimates of $10.71 million. ProPhase Labs had a negative net margin of 37.81% and a negative return on equity of 29.83%. On average, analysts expect ProPhase Labs to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

ProPhase Labs Stock Down 5.2 %

NASDAQ PRPH opened at $5.06 on Wednesday. The stock has a market capitalization of $91.33 million, a P/E ratio of -5.16 and a beta of -0.17. ProPhase Labs has a 52 week low of $4.05 and a 52 week high of $9.94. The company has a debt-to-equity ratio of 0.29, a quick ratio of 2.10 and a current ratio of 2.28. The stock has a fifty day moving average of $5.54 and a 200-day moving average of $5.04.

Analyst Ratings Changes

Separately, HC Wainwright reiterated a “buy” rating and set a $11.00 price target on shares of ProPhase Labs in a research report on Wednesday, February 21st.

About ProPhase Labs

ProPhase Labs, Inc develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster.